$14.5 Billion Solstice–Element Merger Ends After Shareholder Pushback
Solstice OKs a $500M buyback and reaffirms 2026 guidance.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Solstice OKs a $500M buyback and reaffirms 2026 guidance.
Affirm Q4 revenue rose 33% to $1.17B and GMV hit $14.1B, beating estimates. Profit jumped on a tax gain. Next-quarter outlook also topped Street.
IREN added Cohere, Perplexity and Figure AI, plus a multi-year frontier-lab deal.
Gap raised its full-year profit forecast after the namesake brand posted 10% comps growth, beating EPS estimates despite a sales miss.
Marvell posted record $2.74B revenue and beat EPS, yet shares fell after hours as Q3 gross-margin guidance slipped on custom-chip mix.
Investors worry about Baudouin engines in Generac’s 2.25–3.25 MW data-center units. Wells Fargo: mostly standby U.S.-assembled packages.